IRADIMED CORPORATION Finite-Lived Intangible Asset, Expected Amortization, Year One
IRADIMED CORPORATION (IRMD) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $431.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $431.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $370.00K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $440.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $440.18K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $431.00K 10-Q · filed 2026-07-31 |
| 2026-03-31 | $370.00K 10-Q · filed 2026-05-01 |
| 2025-12-31 | $440.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $440.18K 10-Q · filed 2025-11-03 |
| 2025-06-30 | $436.09K 10-Q · filed 2025-08-01 |
| 2025-03-31 | $226.63K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $235.70K 10-K/A · filed 2025-09-03 |
| 2024-09-30 | $235.70K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $226.16K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $226.16K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $229.33K 10-K · filed 2024-03-01 |
| 2023-09-30 | $100.54K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $100.54K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $100.54K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $100.95K 10-K · filed 2023-03-02 |
| 2022-09-30 | $100.95K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $100.95K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $99.80K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $100.31K 10-K · filed 2022-03-04 |
| 2021-09-30 | $100.31K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $100.31K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $99.70K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $100.27K 10-K · filed 2021-03-05 |
| 2019-12-31 | $89.96K 10-K · filed 2020-03-06 |
| 2018-12-31 | $89.96K 10-K · filed 2019-03-07 |
| 2017-12-31 | $82.40K 10-K · filed 2018-03-08 |
| 2016-12-31 | $10.54K 10-K · filed 2017-03-10 |
| 2015-12-31 | $18.02K 10-K · filed 2016-03-10 |
| 2014-12-31 | $39.45K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |